购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 Target 筛选
  • Autophagy
    (1)
  • Calcium Channel
    (1)
  • Histamine Receptor
    (1)
  • PAFR
    (1)
  • Others
    (1)
筛选
搜索结果
TargetMol产品目录中 "

ur 12592

"的结果
  • 抑制剂&激动剂
    4
    TargetMol | Inhibitors_Agonists
  • 同位素
    1
    TargetMol | Isotope_Products
AzelnidipineCS 905,阿折地平,UR-12592
T0121123524-52-7
Azelnidipine (UR-12592) 是二氢吡啶衍生物,是 L 型钙离子通道阻断剂,有抗高血压作用。
  • ¥ 163
现货
规格
数量
TargetMol | Inhibitor Sale
TargetMol | Citations 客户已引用
Rupatadine Fumarate富马酸卢帕他定,Rinialer,Rupafin,Alergoliber
T6242182349-12-8
Rupatadine Fumarate (Rinialer) 是一种可口服的长效PAF H1受体的双抑制剂,Ki 值分别为 0.55 μM 和 0.1 μM。它可研究过敏性鼻炎和荨麻疹。
  • ¥ 147
现货
规格
数量
Rupatadine卢帕他定
T36618158876-82-5
Rupatadine (UR-12592) is a potent dual PAF H1 antagonist with Ki of 0.55 0.1 uM(rabbit platelet membranes guinea pig cerebellum membranes).IC50 value:Target: PAF H1 antagonistin vitro: Rupatadine competitively inhibited histamine-induced guinea pig ileum contraction (pA2 = 9.29 + - 0.06) without affecting contraction induced by ACh, serotonin or leukotriene D4 (LTD4). It also competitively inhibited PAF-induced platelet aggregation in washed rabbit platelets (WRP) (pA2 = 6.68 + - 0.08) and in human platelet-rich plasma (HPRP) (IC50 = 0.68 microM), while not affecting ADP- or arachidonic acid-induced platelet aggregation [1]. The IC50 for rupatadine in A23187, concanavalin A and anti-IgE induced histamine release was 0.7+ -0.4 microM, 3.2+ -0.7 microM and 1.5+ -0.4 microM, respectively whereas for loratadine the IC50 was 2.1+ -0.9 microM, 4.0+ -1.3 M and 1.7+ -0.5 microM. SR-27417A exhibited no inhibitory effect [2].in vivo: Rupatadine blocked histamine- and PAF-induced effects in vivo, such as hypotension in rats (ID50 = 1.4 and 0.44 mg kg i.v., respectively) and bronchoconstriction in guinea pigs (ID50 = 113 and 9.6 micrograms kg i.v.). Moreover, it potently inhibited PAF-induced mortality in mice (ID50 = 0.31 and 3.0 mg kg i.v. and p.o., respectively) and endotoxin-induced mortality in mice and rats (ID50 = 1.6 and 0.66 mg kg i.v.) [1]. rupatadine treatment improved the declined lung function and significantly decreased animal death. Moreover, rupatadine was able not only to attenuate silica-induced silicosis but also to produce a superior therapeutic efficacy compared to pirfenidone, histamine H1 antagonist loratadine, or PAF antagonist CV-3988 [3]. [1]. Merlos M, et al. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF). J Pharmacol Exp Ther. 1997 Jan;280(1):114-21. [2]. Queralt M, et al. In vitro inhibitory effect of rupatadine on histamine and TNF-alpha release from dispersed canine skin mast cells and the human mast cell line HMC-1. Inflamm Res. 2000 Jul;49(7):355-60. [3]. Lv XX, et al. Rupatadine protects against pulmonary fibrosis by attenuating PAF-mediated senescence in rodents. PLoS One. 2013 Jul 15;8(7):e68631.
  • ¥ 851
5日内发货
规格
数量
TargetMol | Citations 客户已引用
Rupatadine-d4 Fumarate卢帕他定-d4 富马酸盐
TMIJ-01161795153-63-7
Rupatadine-d4 Fumarate 是 Rupatadine Fumarate 的氘代化合物。Rupatadine Fumarate 的 CAS 号为 182349-12-8。Rupatadine Fumarate 是一种可口服的长效PAF H1受体的双抑制剂,Ki值分别为 0.55 μM 和 0.1 μM。它可研究过敏性鼻炎和荨麻疹。
  • 询价
20日内发货
规格
数量